Osborne Clarke advised Creo Medical Group Plc on the deal. Creo Medical Group PLC, an AIM-quoted medical devices company focusing on the emerging field of surgical...
Creo Medical’s £17 Million Fundraise
Cavendish Capital Markets Ltd’s £21 Million Fundraise For Acquisition Of Autotrak
Osborne Clarke advised Cavendish on the deal. Cavendish Capital Markets Limited completed the conditional £20 million placing and up to £1 million retail offer for AIM-quoted...
Wilmington Plc’s £48.5 Million Sale Of Its European Healthcare Business
Osborne Clarke has advised Wilmington Plc on the deal. Wilmington plc, the UK listed provider of data, information, education and training in the global Governance, Risk...
TheWorks.co.uk plc’s Admission To AIM
Osborne Clarke advised Singer Capital Markets, in its capacity as nominated adviser on TheWorks.co.uk plc’s move to AIM from the Main Market. The Works is one...
The Property Franchise Group Plc’s £214 Million All-Share Merger With Belvoir Group Plc
Osborne Clarke advised The Property Franchise Group PLC on the deal. AIM-quoted The Property Franchise Group PLC, a leading property franchisor in the UK and manager...
Chapel Down Group’s Admission on AIM From Aquis Stock Exchange
Osborne Clarke advised Singer Capital Markets on Chapel Down’s admission to AIM. Singer Capital Markets, acted as nominated adviser on Chapel Down Group plc’s move to AIM...
Phoenix Equity Partners’ Acquisition of 4most
Osborne Clarke has advised 4most. 4most, a leading provider of risk analytics and modelling solutions to banks and insurers, and its management team on the sale...
Destiny Pharma plc’s £8 Million Fundraise
Osborne Clarke advised finnCap Ltd and Shore Capital Stockbrokers Limited. The transaction involved the conditional £7 million placing and subscription and up to £1m open offer...
Yourgene Health plc’s £7.4 Million Fundraise
Osborne Clarke has advised Singer Capital Markets Securities Limited on the deal. Singer Capital Markets Securities Limited was involved in the conditional £6.4 million placing for...
Carta’s Acquisition of Capdesk
Osborne Clarke advised Capdesk on the deal. Capdesk announced its acquisition by Silicon Valley-based global equity ownership management platform, Carta. The acquisition is founded on Capdesk...
Redx Pharma plc’s £34.3 Million Placing
Osborne Clarke has advised WG Partners LLP, Panmure Gordon (UK) Limited and Stifel Nicolaus Europe Limited. WG Partners LLP, Panmure Gordon (UK) Limited and Stifel Nicolaus...
Ebiquity plc’s £15 Million Placing and Acquisitions of MediaPath and MMi
Osborne Clarke has advised Ebiquity plc on the deal. Ebiquity plc, a world leader in media investment analysis, on its successful and significantly over-subscribed £15 million...